Jiajie Zhang

4.5k total citations · 1 hit paper
144 papers, 3.4k citations indexed

About

Jiajie Zhang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiajie Zhang has authored 144 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 28 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiajie Zhang's work include Cancer therapeutics and mechanisms (16 papers), Quinazolinone synthesis and applications (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Jiajie Zhang is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Quinazolinone synthesis and applications (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Jiajie Zhang collaborates with scholars based in China, United States and Taiwan. Jiajie Zhang's co-authors include Guangfa Wang, Shaoyu Wu, Yuanxin Tian, Zhonghuang Li, Shanhe Wan, Vimla L. Patel, Todd R. Johnson, Edward H. Shortliffe, John B. Holcomb and Erin E. Fox and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Gastroenterology.

In The Last Decade

Jiajie Zhang

136 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study

2012 733 citations Jiajie Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiajie Zhang China	30	1.1k	699	650	486	365	144	3.4k
Antonella Marino Italy	40	2.4k 2.2×	293 0.4×	257 0.4×	363 0.7×	327 0.9×	157	5.0k
Zhiyong Peng China	32	1.6k 1.4×	508 0.7×	288 0.4×	672 1.4×	476 1.3×	152	5.9k
Hernando Gómez United States	26	1.6k 1.5×	805 1.2×	329 0.5×	878 1.8×	213 0.6×	70	6.0k
Kensuke Nakamura Japan	27	1.1k 1.0×	739 1.1×	133 0.2×	377 0.8×	57 0.2×	205	3.4k
Stephen L. Barnes United States	24	426 0.4×	160 0.2×	449 0.7×	464 1.0×	260 0.7×	80	2.8k
Francisco J. López‐Hernández Spain	28	1.1k 1.0×	106 0.2×	99 0.2×	268 0.6×	409 1.1×	104	3.9k
Junichi Hasegawa Japan	40	1.6k 1.5×	61 0.1×	129 0.2×	886 1.8×	350 1.0×	363	5.8k
Takeshi Ishii Japan	38	1.5k 1.4×	72 0.1×	87 0.1×	378 0.8×	493 1.4×	159	4.3k
Avraham Yacobi United States	32	1.3k 1.2×	103 0.1×	156 0.2×	255 0.5×	648 1.8×	128	6.0k
Ken Ng Australia	39	1.1k 1.0×	245 0.4×	40 0.1×	417 0.9×	159 0.4×	118	4.5k

Countries citing papers authored by Jiajie Zhang

Since Specialization

Citations

This map shows the geographic impact of Jiajie Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajie Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajie Zhang more than expected).

Fields of papers citing papers by Jiajie Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajie Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajie Zhang. The network helps show where Jiajie Zhang may publish in the future.

Co-authorship network of co-authors of Jiajie Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajie Zhang. A scholar is included among the top collaborators of Jiajie Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajie Zhang. Jiajie Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Chuqiao, Chunsheng Kang, Shan Huang, et al.. (2025). Computational fluid dynamics simulation of temperature distribution in heated and stirred pilot-scale methanogenic reactor. Journal of Cleaner Production. 492. 144883–144883.

Zhang, Jianxin, et al.. (2025). The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer and colorectal anastomotic leakage patients: a retrospective study. BMC Surgery. 25(1). 57–57. 6 indexed citations

Wang, Weiyu, Shu Lian, Xiaodong Xie, et al.. (2025). TGF-β secreted by cancer cells-platelets interaction activates cancer metastasis potential by inducing metabolic reprogramming and bioenergetic adaptation. Journal of Cancer. 16(4). 1310–1323. 2 indexed citations

Wang, Shuyi, Xiaotian Xu, Qian Guo, et al.. (2024). Identification of New EGFR Inhibitors by Structure-Based Virtual Screening and Biological Evaluation. International Journal of Molecular Sciences. 25(3). 1887–1887. 6 indexed citations

Zhao, Zean, Xinhua Chen, Jiajun Luo, et al.. (2024). Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents. European Journal of Medicinal Chemistry. 277. 116753–116753. 3 indexed citations

Liu, Siming, Chuan Huang, Chunhui Huang, et al.. (2023). Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1 ^G2032R and ALK ^G1202R. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2227779–2227779. 6 indexed citations

Jiang, Ying, Chunhui Huang, Guowu Wu, et al.. (2023). A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma. Pharmaceutics. 15(5). 1501–1501. 5 indexed citations

Wang, Jie, et al.. (2022). Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment. Frontiers in Oncology. 12. 833894–833894. 2 indexed citations

Li, Jie, Jiajie Zhang, Qi Long, Weisheng Guo, & Menghua Xiong. (2022). Modulation of Conformational Transition of Polypeptides under Slightly Acidic Environment^†. Chinese Journal of Chemistry. 40(24). 2981–2987. 7 indexed citations

10.

Sendi, Hossein, Mostafa Yazdimamaghani, Mengying Hu, et al.. (2021). Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis. Cancer Research. 82(1). 105–113. 53 indexed citations

11.

Yang, Hai‐Kui, Ying Jiang, Zichao Yang, et al.. (2019). Design, synthesis and biological evaluation of 2-amino-4-(1,2,4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance. European Journal of Medicinal Chemistry. 187. 111966–111966. 20 indexed citations

12.

Liu, Siming, Ying Jiang, Zhonghuang Li, et al.. (2019). Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors. European Journal of Medicinal Chemistry. 179. 358–375. 26 indexed citations

13.

Pan, Hongying, et al.. (2019). Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae : Microbiological Characteristics and Risk Factors. Microbial Drug Resistance. 25(2). 287–296. 25 indexed citations

14.

Wang, Mingshan, et al.. (2019). LncRNA HOXA-AS3 Sponges miR-29c to Facilitate Cell Proliferation, Metastasis, and EMT Process and Activate the MEK/ERK Signaling Pathway in Hepatocellular Carcinoma. PubMed. 30(3). 129–141. 32 indexed citations

15.

Zhao, Tingting, Zean Zhao, Shan Chang, et al.. (2019). Two- and three-dimensional QSAR studies on hURAT1 inhibitors with flexible linkers: topomer CoMFA and HQSAR. Molecular Diversity. 24(1). 141–154. 12 indexed citations

16.

Zhang, Tingting, Yuanxin Tian, Zhonghuang Li, et al.. (2017). Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling. 57(9). 2281–2293. 15 indexed citations

17.

Tian, Yuanxin, Yu‐Dong Shen, Shan Chang, et al.. (2017). Molecular Simulation Studies on the Binding Selectivity of Type-I Inhibitors in the Complexes with ROS1 versus ALK. Journal of Chemical Information and Modeling. 57(4). 977–987. 16 indexed citations

18.

Tian, Yuanxin, Tingting Zhang, Zhonghuang Li, et al.. (2017). Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors. European Journal of Medicinal Chemistry. 143. 182–199. 13 indexed citations

19.

Wang, Guangfa, Junyan Zhang, Shaoyu Wu, et al.. (2010). Praeruptorin a inhibits lipopolysaccharide‐induced inflammatory response in murine macrophages through inhibition of NF‐κB pathway activation. Phytotherapy Research. 25(4). 550–556. 33 indexed citations

20.

Turley, James P., et al.. (2006). Safety Studies in Cognitive Science: Comprehensive Medical Error Ontology for the Codification of Published Literature. 13(1). 6–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact